Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease

The goal of this study is to evaluate the safety and tolerability of TG-C in subjects with chronic discogenic lumbar back pain due to degenerative disc disease. Participants will be administered a single intradiscal injection or subcutaneous injection for sham and followed up with in-clinic visits and telephone calls for 24 months.

Participants needed: 24
Trial details
Phase: Phase 1Age: 22-70Biological sex: AllType: InterventionalSponsor: Kolon TissueGene, Inc.Updated: May 27, 2026
Eligibility criteria

Between the ages of >= 22 and <= 70 [+11]

Co-morbid medical condition of the spine or upper extremities [+24]

Read more
Status: Not yet recruiting

A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Determine the Efficacy, Safety, and Dosing of TG-C in Adult Subjects with Symptomatic Early Hip Osteoarthritis. TG-C will be administered to the target hip by a single ultrasound (or fluoroscopy)-guided, intra-articular injection with image capture showing correct injection of study drug into the femoroacetabular joint. Patients will be followed for 12 months for safety and efficacy.

Participants needed: 255
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Kolon TissueGene, Inc.Updated: May 22, 2026
Eligibility criteria

Aged 18 to 80 years old [+8]

The subject exhibits severe symptoms in the target hip that result in difficulty... [+23]

Read more